Long-Term Mpox Sequelae 11 to 18 Months After Acute Illness : A Cohort Study in Two U.S. Cities.

Key Points

• To investigate the long-term health effects of mpox 11 to 18 months after acute illness.
• Conducted a cohort study in two U.S. cities
• Followed individuals with a history of mpox
• Collected health outcome data over 11 to 18 months
• Identified significant health challenges related to mpox sequelae
• Reported various long-term symptoms affecting daily life
• Highlighted the need for continued monitoring of health outcomes